Learn about the latest advancements in immunotherapy research focusing on harnessing IL-12 for the treatment of ovarian cancer to potentially improve survival rates.

Cancer Gene Therapy - Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial Skip to main content Thank you for visiting nature.com.

Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute found that combining Ziopharm’s small-molecule oral drug veledimex with an IL-12 gene therapy was safe in an ...

Background: We investigated whether immune system impairment manifested by increased Interleukin-10 (IL-10) and reduced IL-12 levels occur in breast cancer patients and determined the effect of ...

A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) ⎯ a potent immune-boosting protein that holds promise for cancer treatment ...

This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor destruction in aggressive cancer models.

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...